Ironwood Pharma (IRWD) Tops Q4 EPS by 7c

Ironwood Pharma (NASDAQ: IRWD) reported Q4 EPS of ($0.10), $0.07 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $53.3 million versus the consensus estimate of $45.55 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• BIG3 Basketball to go public via Graf Global merger at $290 million